Gastroparesis Exacerbation by a GLP-1 Agonist. Journal of the Endocrine Society, vol
The demonstrated success with liraglutide, a commercially significant peptide therapeutic, makes this particularly relevant for organizations considering their manufacturing strategy in the growing GLP-1 market
Tune in to hear Suzy Badaracco, president of Culinary Tides, and Sherry Frey, vice president, Total Wellness, NielsenIQ, in a conversation guided by Michael Costa, managing editor of Food Business News , as they highlight the effect GLP-1 medications are having on consumer packaged goods companies
Which vitamin injections are best for boosting the immune system
Thats especially true given the mystery for why people with Type 2 diabetes (for which these drugs were used for many years) did not exhibit much in the way of weight loss